Immunogenicity of inactivated 2009 H1N1 influenza vaccine in pediatric liver transplant recipients

Vaccine

Volumn 29, Issue 25, 2011, Pages 4187-4189

  Torii, Yuka ^a   Kimura, Hiroshi ^a   Ochi, Nobuhiko ^b   Kaneko, Kenitiro ^a   Ando, Hisami ^a   Kiuchi, Tetsuya ^a   Ito, Yoshinori ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b National Rehabilitation Center for the Disabled   (Japan)

Author keywords

2009 H1N1; Immunogenicity; Influenza vaccination; Liver transplantation

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOGENICITY; INFLUENZA VACCINATION; JAPANESE; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; RECIPIENT; SEASONAL INFLUENZA; SEROCONVERSION; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LIVER TRANSPLANTATION; MALE; TRANSPLANTATION; VACCINES, INACTIVATED;

EID: 79956206662     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.04.012     Document Type: Article

References (19)

1. Kumar D., Michaels M., Morris M., Green M., Avery R., Liu C., et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis 2010, (July).
2. Mauch T., Bratton S., Myers T., Krane E., Gentry S., Kashtan C., et al. Virus infection in pediatric solid organ transplant recipients. Pediatrics 1994, 94(August (2 Pt 1)):225-229.
3. Vilchez R., Fung J., Kusne S. The pathogenesis and management of influenza virus infection in organ transplant recipients. Transpl Infect Dis 2002, 4(December (4)):177-182.
4. Apalsch A.M., Green M., Ledesma-Medina J., Nour B., Wald E.R. Parainfluenza and influenza virus infections in pediatric organ transplant recipients. Clin Infect Dis 1995, 20(February (2)):394-399.
5. Mack D., Chartrand S., Ruby E., Antonson D., Shaw B.J., Heffron T. Influenza vaccination following liver transplantation in children. Liver Transpl Surg 1996, 2(November (6)):431-437.
6. Burbach G., Bienzle U., Stark K., Rayes N., Neuhaus R., Serke S., et al. Influenza vaccination in liver transplant recipients. Transplantation 1999, 67(March (5)):753-755.
7. Soesman N., Rimmelzwaan G., Nieuwkoop N., Beyer W., Tilanus H., Kemmeren M., et al. Efficacy of influenza vaccination in adult liver transplant recipients. J Med Virol 2000, 61(May (1)):85-93.
8. Duchini A., Hendry R., Nyberg L., Viernes M., Pockros P. Immune response to influenza vaccine in adult liver transplant recipients. Liver Transpl 2001, 7(April (4)):311-313.
9. Madan R., Tan M., Fernandez-Sesma A., Moran T., Emre S., Campbell A., et al. A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings. Clin Infect Dis 2008, 46(March (5)):712-718.
10. Gaeta G., Pariani E., Amendola A., Brancaccio G., Cuomo G., Stornaiuolo G., et al. Influenza vaccination in patients with cirrhosis and in liver transplant recipients. Vaccine 2009, 27(May (25-26)):3373-3375.
11. Gotoh K., Ito Y., Suzuki E., Kaneko K., Kiuchi T., Ando H., et al. Effectiveness and safety of inactivated influenza vaccination in pediatric liver transplant recipients over three influenza seasons. Pediatr Transplant 2010, (November).
12. WHO. WHO manual on animal influenza diagnosis and surveillance. 2002 [cited 2010 Dec 10]; Available from: http://www.who.int/vaccine_research/diseases/influenza/WHO_manual_on_animal-diagnosis_and_surveillance_2002_5.pdf.
13. Greenberg M., Lai M., Hartel G., Wichems C., Gittleson C., Bennet J., et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009, 361(December (25)):2405-2413.
14. Nolan T., McVernon J., Skeljo M., Richmond P., Wadia U., Lambert S., et al. Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. JAMA 2010, 303(January (1)):37-46.
15. Plennevaux E., Sheldon E., Blatter M., Reeves-Hoche M.K., Denis M. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. Lancet 2010, 375(January (9708)):41-48.
16. Liang X., Wang H., Wang J., Fang H., Wu J., Zhu F., et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2010, 375(January):56-66. (9708):.
17. Oh C., Lee J., Kang J., Hong Y., Kim Y., Cheong H., et al. Safety and immunogenicity of an inactivated split-virus influenza A/H1N1 vaccine in healthy children from 6 months to <18 years of age. A prospective, open-label, multi-center trial. Vaccine 2010, (June).
18. Girard M.P., Tam J.S., Assossou O.M., Kieny M.P. The 2009 A (H1N1) influenza virus pandemic: a review. Vaccine 2010, 28(July (31)):4895-4902.
19. Vajo Z., Tamas F., Sinka L., Jankovics I. Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial. Lancet 2010, 375(January (9708)):49-55.